Pharma Equity Group A/S Class A
No trades
No trades
Fundamentals and stats
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Pharma Equity Group A/S operates as a biopharmaceutical group that develops the most effective local treatments for serious, acute and chronic inflammatory diseases. The company specializes in repositioning existing drugs and advancing selected candidates to clinical Phase II. It provides a cost-efficient and flexible development environment, enabling the rapid mobilization of relevant resources. The company was founded on September 20, 2002 and is headquartered in Horsholm, Denmark.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
PEG has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company